• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular analysis of B-cell malignant lymphoma-related oncogenes and its clinical application for diagnosis and treatment.

Research Project

Project/Area Number 13671091
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionAichi Cancer Center

Principal Investigator

HOSOKAWA Yoshitaka  Aichi Cancer Center, Div. Molecular Medicine, Section Head, 遺伝子医療研究部, 室長 (60229193)

Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥4,100,000 (Direct Cost: ¥4,100,000)
Fiscal Year 2002: ¥1,600,000 (Direct Cost: ¥1,600,000)
Fiscal Year 2001: ¥2,500,000 (Direct Cost: ¥2,500,000)
KeywordsMalignant lymphoma / Chromosome translocation / apoptosis / BCL6
Research Abstract

1) BCL6. The BCL-6/LAZ3 gene encodes a zinc-finger transcriptional repressor and is located at the breakpoint of the 3q27-associated translocations that occur most frequently in non-Hodgkin's lymphomas (NHLs To examine cell responses and target genes related to the BCL-6 signaling pathway, we established Ba/F3 pro-B cells carrying a human BCL-6 transgene that is inducible under control of the lactose operon. Using a CDNA array hybridization technique, we found that the induced BCL-6 protein can downregulate the expressions of the genes, cyclin A2, chemokine receptor CXCR4, and insulin-like growth factor binding protein-4 (IGFBP-4) in the Ba/F3 cells. Northern blot analysis established that the expressions of these genes were indeed downregulated by the induced BCL-6 protein but in a somewhat different manner. The induced BCL-6 protein also inhibited cell proliferation of Ba/F3 cells. These findings strongly suggest that three key genes, namely cyclin A2, CXCR4 and IGFBP-4 may play a ro … More le in the downstream of the BCL-6 signaling pathway during B - lymphoid differentiation.
2) API2-MALT1. t(11;18)(q21;q21) is a characteristic chromosomal translocation in mucosa-associated lymphoid tissue (MALT) type lymphoma, and this translocation results in chimeric transcript of API2 (Apoptosis Inhibitor 2, also known as c-IAP2) - MALT1 (Mucosa-Associated Lymphoma Translocation gene 1). To identify proteins that bind API2-MALT1 chimeric protein, we employed coimmunoprecipitation and SDS PAGE analysis, followed by liquid chromatography-electrospray ionization tandem mass spectrometry. As a result, Smac, Htra2, and TRAF2 were identified as API2-MALT1-binding proteins. Immunoprecipitation analysis demonstrated that ectopically expressed API2-MALT1 protein indeed binds to these endogeneous proteins. Furthermore, API2-MALT1 protein significantly inhibited Smac-promoted apoptosis in UV irradiated HeLa cells. These data strongly suggest that API2-MALT1 can block apoptosis, at least in part, by inhibiting Smac-mediated apoptotic pathway. Less

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (28 results)

All Other

All Publications (28 results)

  • [Publications] Hosokawa Y, et al.: "In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53"Transgenic Research. 5. 471-478 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Hosokawa Y, et al.: "Target genes downregulated by the BCL6/LAZ3 oncoprotein in mouse Ba/F3 cells"Biochem.Biophy.Res.Commun. 3. 563-568 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Imanishi Y*, Hosokawa Y*: "Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice"J.Clin.Invest.. 9. 1093-1102 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yonezumi M, et al.: "Detection of API2-MALT1 chimeric gene in extranodal and nodal marginal zone B cell lymphoma by RT-PCR and LA-PCR analyses"Br.J.Haematol.. 115. 588-594 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tagawa H, et al.: "Molecular cytogenetic analysis of the breakpoint region at 6q21-22 in T-cell lymphoma/leukemia cell line"Genes Chromo & Cancer. 34. 175-185 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 細川好孝: "造血器腫瘍患者の個性診断-DNAチップの応用"プラクテカル内科シリーズ. 11. 209-212 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Hosokawa Y, Papanikolaou A, Cardiff RD, Yoshimoto K, Bernstein M, Wang TC, Schmidt EV, and Arnold A: "In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53"Transgenie Research. 5. 471-478 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Hosokawa Y, Maeda Y, and Seto M: "Target genes downregulated by the BCL6/LAZ3 oncoprotein in mouse Ba/F3 cells"Biochem. Biophy. Res. Commun.. 3. 563-568 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Imanishi Y^*, Hosokawa Y^*, Yoshimoto K^*, Schipani E, Mallya S, Papanikolaou A, Kifor O, Takahiko T, Sablosky M, Ledgard F, Gronowicz G, Wang TC, Schmidt EV, Hall C, Brown EM, Bronson R, and Arnold A (* equal contributor): "Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice"J. Clin. Invest.. 9. 1093-1102 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yonezumi M, Suzuki R, Suzuki H, Yoshino T, Oshima K , Hosokawa Y, Asaka M, Morishima Y, Nakamura S, Seto M: "Detection of API2-MALT1 chimeric gene in extranodal and nodal marginal zone B cell lymphoma by RT-PCR and LA-PCR analyses"Br. J. Haeraatol.. 115. 588-594 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tagawa H, Miura I, Suzuki R, Suzuki H, Hosokawa Y, and Seto M: "Molecular cytogeneticanalysis of the breakpoint region at 6q21-22 in T-cell lymphoma/leukemia cell line"Genes Chromosomes & Cancer. 34. 175-185 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Sivasundaram K, Suzuki H, Seto M, and Hosokawa Y: "Mutational analysis of the ST7 gene in human myeloid tumor cell lines"Oncology Reports. in press. (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Hosokawa Y et al.: "In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53"Transgenic Research. 5. 471-478 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Hosokawa Y et al.: "Target genes downregulated by the BCL6/LAZ3 oncoprotein in mouse Ba/F3 cells"Biochem. Biophy. Res. Commun.. 3. 563-568 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Imanishi Y*, Hosokawa Y*, et al.: "Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice"J. Clin. Invest.. 9. 1093-1102 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Yonezumi M et al.: "Detection of API2-MALT1 chimeric gene in extranodal and nodal marginal zone B cell lymphoma by RT-PCR and LA-PCR analyses"Br. J. Haematol.. 115. 588-594 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Tagawa H et al.: "Molecular cytogenetic analysis of the breakpoint region at 6q21-22 in T-cell lymphoma/leukemia cell line"Genes Chromosomes & Cancer. 34. 175-185 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 細川好孝: "造血器腫瘍患者の個性診断-DNAチップの応用"プラクテカル内科シリーズ. 11. 209-212 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] 細川好孝: "イカロスによるリンパ球分化制御と造血器腫瘍"Molecular Medicine. 38. 784-789 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] 細川好孝, 瀬戸加大: "MALTリンパ腫の分子機構"血液・腫瘍科. 43. 83-90 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] 細川好孝, 鈴木進, 瀬戸加大: "悪性リンパ腫の分子機構の現状と展望"遺伝子医学. 6. 19-26 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 細川好孝: "Ikaros gene family"生化学「ことば」. 74. 257 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 細川好孝: "DNAチップとその応用"血液の事典 朝倉書店. (印刷中). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Hosokawa et al.: "In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53"Transgenic Research. 5. 471-478 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Hosokawa et al.: "Target genes downregulated by the BCL6/LAZ3 oncoprotein in mouse Ba/F3 cells"Biochem.Biophy.Res.Commun.. 3. 563-568 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Imanishi et al.: "Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice"J.Clin.Invest.. 9. 1093-1102 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yonezumi et al.: "Detection of API2-MALT1 chimeric gene in extranodal and nodal marginal zone B cell lymphoma by RT-PCR and LA-PCR analyses"Br.J.Haematol.. 115. 588-594 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Tagawa et al.: "Molecular cytogenetic analysis of the breakpoint region at 6q21-22 in T-cell lymphoma/leukemia cell line"Genes Chromosomes & Cancer 2002. (in press).

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi